Literature DB >> 16357561

Thyroid carcinoma.

Theresia Weber1, Tobias Schilling, Markus W Büchler.   

Abstract

PURPOSE OF REVIEW: Diagnostic methods and treatment options for differentiated and medullary thyroid carcinoma are continuously influenced by new trends and techniques. Our review therefore displays the most recent clinical practices for diagnosis and operative treatment of differentiated and medullary thyroid carcinoma. RECENT
FINDINGS: Among the new diagnostic methods, high-resolution ultrasonography plays an important role for both the evaluation of thyroid nodules and the detection of enlarged suspicious cervical lymph nodes. The results of ultrasound will definitely influence operative decisions. A second step to diagnose medullary thyroid carcinoma is calcitonin measurement before surgery, which is sensitive and specific enough to detect medullary thyroid carcinoma in patients with thyroid nodules. Surgical treatment for differentiated or medullary thyroid carcinoma mostly consists of total or near-total thyroidectomy. An additional central or lateral modified-radical neck dissection might help to reduce local recurrence, especially in medullary carcinoma, but still does not influence significantly the survival rates. Monitoring of the recurrent laryngeal nerve during surgery is used increasingly. According to the newest literature, however, compared with visual identification of the laryngeal nerve, it cannot be considered as superior.
SUMMARY: Diagnosis and treatment of thyroid carcinoma are still subjected to changes and the different options of surgical treatment in particular will be continuously discussed in the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16357561     DOI: 10.1097/01.cco.0000198975.36368.d3

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  9 in total

Review 1.  RET TKI: potential role in thyroid cancers.

Authors:  Alessandro Antonelli; Poupak Fallahi; Silvia Martina Ferrari; Caterina Mancusi; Michele Colaci; Libero Santarpia; Clodoveo Ferri
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

2.  Alternative surgical strategies in patients with sporadic medullary thyroid carcinoma: Long-term follow-up.

Authors:  Shi Hong Ma; Qin Jiang Liu; You Cheng Zhang; Rong Yang
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

3.  [Signal stability as key requirement for continuous intraoperative neuromonitoring].

Authors:  W Lamadé; C Ulmer; C Friedrich; F Rieber; K Schymik; H M Gemkow; K P Koch; T Göttsche; K P Thon
Journal:  Chirurg       Date:  2011-10       Impact factor: 0.955

4.  Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

Authors:  G Calò; E Erdas; F Medas; L Gordini; A Longheu; G Pisano; A Nicolosi
Journal:  G Chir       Date:  2015 Nov-Dec

5.  Malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and treated simultaneously: A case report.

Authors:  Alpaslan Ozgun; Tolga Tuncel; Levent Emirzeoglu; Serkan Celik; Oguz Bilgi; Abdullah Haholu; Muammer Urhan; Bulent Karagoz
Journal:  Oncol Lett       Date:  2014-10-27       Impact factor: 2.967

6.  MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.

Authors:  Alf Spitschak; Claudia Meier; Bhavani Kowtharapu; David Engelmann; Brigitte M Pützer
Journal:  Mol Cancer       Date:  2017-01-26       Impact factor: 27.401

7.  Predictive Factors of Recurrence in Patients with Differentiated Thyroid Carcinoma: A Retrospective Analysis on 579 Patients.

Authors:  Fabio Medas; Gian Luigi Canu; Francesco Boi; Maria Letizia Lai; Enrico Erdas; Pietro Giorgio Calò
Journal:  Cancers (Basel)       Date:  2019-08-22       Impact factor: 6.639

8.  Evaluation of accuracy of one-step nucleic acid amplification (OSNA) in diagnosis of lymph node metastases of papillary thyroid carcinoma. Diagnostic study.

Authors:  Fabio Medas; Pierpaolo Coni; Francesco Podda; Claudia Salaris; Federico Cappellacci; Gavino Faa; Pietro Giorgio Calò
Journal:  Ann Med Surg (Lond)       Date:  2019-08-21

9.  FNA of misclassified primary malignant neoplasms of the thyroid: Impact on clinical management.

Authors:  Sejal S Shah; William C Faquin; Roberto Izquierdo; Kamal K Khurana
Journal:  Cytojournal       Date:  2009-01-19       Impact factor: 2.091

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.